Plus   Neg

Achillion Pharmaceuticals Inc. (ACHN) Has Jumped To A 5-Month High

Deutsche Bank initiated coverage of Achillion Pharmaceuticals Inc. (ACHN) Wednesday morning, with a "Buy" rating.

Achillion Pharmaceuticals has gapped open sharply higher this morning and is now up 1.42 at $9.52 on above average volume. The stock has been rising for over a month and has set a 5-month high.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Follow RTT